Profilo
Lee Swem formerly worked at Achaogen, Inc., as Chief Scientific Officer from 2017 to 2018.
Dr. Swem received his doctorate degree from Indiana University.
Precedenti posizioni note di Lee Swem
| Società | Posizione | Fine |
|---|---|---|
| ACHAOGEN | Direttore Tecnico/Scientifico/R&S | 24/09/2018 |
Formazione di Lee Swem
| Indiana University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Lee Swem
